Two Sigma Investments
ENVB icon

Two Sigma Investments’s Enveric Biosciences ENVB Stock Holding History

Two Sigma Investments’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-67
Closed -$4.35K – 3278
2024
Q4 		$4.35K Sell
67
-7
-9% -$508 ﹤0.01% 3152
2024
Q3 		$6.34K Buy
+74
New +$6.81K ﹤0.01% 3061
2024
Q2 		– Sell
-86
Closed -$15.4K – 3112
2024
Q1 		$15.4K Buy
+86
New +$16.6K ﹤0.01% 2939
2022
Q1 		– Sell
-5
Closed -$39K – 3165
2021
Q4 		$39K Hold
5
– – ﹤0.01% 4152
2021
Q3 		$91K Buy
+5
New +$97.1K ﹤0.01% 4092

Other funds holding ENVB

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Investments's ENVB Position: Q1 2025 in Review

Two Sigma Investments sold out of Enveric Biosciences (ENVB) in Q1 2025, closing a stake of 67 shares — an estimated $4.35K sold.

Two Sigma Investments first reported a position in ENVB in Q3 2021 and held it in 5 quarters. The position peaked at $91K in Q3 2021. 13 funds tracked by Wall St. Rank hold ENVB as of Q1 2025.

  • Two Sigma Investments reported no remaining Enveric Biosciences position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Investments sold 67 Enveric Biosciences shares in Q1 2025, an estimated $4.35K.
  • Two Sigma Investments first reported a position in Enveric Biosciences in Q3 2021 and held it in 5 quarters.
  • Two Sigma Investments's Enveric Biosciences position peaked at $91K in Q3 2021.
  • 13 funds tracked by Wall St. Rank held Enveric Biosciences as of Q1 2025.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.